Cargando…

Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease

BACKGROUND: Prolonged P wave duration is a marker of delayed inter-atrial conduction which may predict cardiovascular disease (CVD). Type 2 diabetes is a risk factor for all atherosclerotic manifestations including stroke. We evaluated the prognostic significance of prolonged P wave duration among m...

Descripción completa

Detalles Bibliográficos
Autores principales: Vepsäläinen, Teemu, Laakso, Markku, Lehto, Seppo, Juutilainen, Auni, Airaksinen, Juhani, Rönnemaa, Tapani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280689/
https://www.ncbi.nlm.nih.gov/pubmed/25425321
http://dx.doi.org/10.1186/1471-2261-14-168
_version_ 1782350878805590016
author Vepsäläinen, Teemu
Laakso, Markku
Lehto, Seppo
Juutilainen, Auni
Airaksinen, Juhani
Rönnemaa, Tapani
author_facet Vepsäläinen, Teemu
Laakso, Markku
Lehto, Seppo
Juutilainen, Auni
Airaksinen, Juhani
Rönnemaa, Tapani
author_sort Vepsäläinen, Teemu
collection PubMed
description BACKGROUND: Prolonged P wave duration is a marker of delayed inter-atrial conduction which may predict cardiovascular disease (CVD). Type 2 diabetes is a risk factor for all atherosclerotic manifestations including stroke. We evaluated the prognostic significance of prolonged P wave duration among middle-aged Finnish type 2 diabetes patients with and without prevalent non-major macrovascular disease (PNMMVD) with respect to total and stroke mortality. METHODS: We followed up for 18 years 739 type 2 diabetic patients without previous major CVD event at baseline. Participants were stratified according to P wave duration (<114 or ≥114 ms) and PNMMVD (i.e. coronary heart disease defined as ischaemic ECG changes and typical symptoms of angina pectoris, or claudication; yes or no). The Cox proportional hazards model was used to estimate the joint association between P wave duration, PNMMVD and the mortality risk. RESULTS: During the follow-up, 509 patients died, and 59 of them died from stroke. Those who had prolonged P wave duration had 2.45 (95% confidence interval: 1.11-5.37) increased stroke mortality among PNMMVD patients. In patients without PNMMVD, there was no relationship between P wave duration and stroke mortality. CONCLUSIONS: As an easily measurable factor P wave duration merits further studies with higher number of patients to evaluate its importance in the estimation of stroke risk in type 2 diabetic patients with PNMMVD.
format Online
Article
Text
id pubmed-4280689
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42806892015-01-01 Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease Vepsäläinen, Teemu Laakso, Markku Lehto, Seppo Juutilainen, Auni Airaksinen, Juhani Rönnemaa, Tapani BMC Cardiovasc Disord Research Article BACKGROUND: Prolonged P wave duration is a marker of delayed inter-atrial conduction which may predict cardiovascular disease (CVD). Type 2 diabetes is a risk factor for all atherosclerotic manifestations including stroke. We evaluated the prognostic significance of prolonged P wave duration among middle-aged Finnish type 2 diabetes patients with and without prevalent non-major macrovascular disease (PNMMVD) with respect to total and stroke mortality. METHODS: We followed up for 18 years 739 type 2 diabetic patients without previous major CVD event at baseline. Participants were stratified according to P wave duration (<114 or ≥114 ms) and PNMMVD (i.e. coronary heart disease defined as ischaemic ECG changes and typical symptoms of angina pectoris, or claudication; yes or no). The Cox proportional hazards model was used to estimate the joint association between P wave duration, PNMMVD and the mortality risk. RESULTS: During the follow-up, 509 patients died, and 59 of them died from stroke. Those who had prolonged P wave duration had 2.45 (95% confidence interval: 1.11-5.37) increased stroke mortality among PNMMVD patients. In patients without PNMMVD, there was no relationship between P wave duration and stroke mortality. CONCLUSIONS: As an easily measurable factor P wave duration merits further studies with higher number of patients to evaluate its importance in the estimation of stroke risk in type 2 diabetic patients with PNMMVD. BioMed Central 2014-11-25 /pmc/articles/PMC4280689/ /pubmed/25425321 http://dx.doi.org/10.1186/1471-2261-14-168 Text en © Vepsäläinen et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Vepsäläinen, Teemu
Laakso, Markku
Lehto, Seppo
Juutilainen, Auni
Airaksinen, Juhani
Rönnemaa, Tapani
Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease
title Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease
title_full Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease
title_fullStr Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease
title_full_unstemmed Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease
title_short Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease
title_sort prolonged p wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280689/
https://www.ncbi.nlm.nih.gov/pubmed/25425321
http://dx.doi.org/10.1186/1471-2261-14-168
work_keys_str_mv AT vepsalainenteemu prolongedpwavedurationpredictsstrokemortalityamongtype2diabeticpatientswithprevalentnonmajormacrovasculardisease
AT laaksomarkku prolongedpwavedurationpredictsstrokemortalityamongtype2diabeticpatientswithprevalentnonmajormacrovasculardisease
AT lehtoseppo prolongedpwavedurationpredictsstrokemortalityamongtype2diabeticpatientswithprevalentnonmajormacrovasculardisease
AT juutilainenauni prolongedpwavedurationpredictsstrokemortalityamongtype2diabeticpatientswithprevalentnonmajormacrovasculardisease
AT airaksinenjuhani prolongedpwavedurationpredictsstrokemortalityamongtype2diabeticpatientswithprevalentnonmajormacrovasculardisease
AT ronnemaatapani prolongedpwavedurationpredictsstrokemortalityamongtype2diabeticpatientswithprevalentnonmajormacrovasculardisease